首页> 美国卫生研究院文献>Osong Public Health and Research Perspectives >The 2nd Meeting of National Control Laboratories for Vaccines and Biologicals in the Western Pacific
【2h】

The 2nd Meeting of National Control Laboratories for Vaccines and Biologicals in the Western Pacific

机译:西太平洋国家疫苗和生物制剂国家控制实验室第二次会议

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The Second Meeting of the National Control Laboratories for Vaccines and Biologicals in the Western Pacific, was jointly organized by the National Institute of Food and Drug Safety Evaluation of the Ministry of Food and Drug Safety in the Republic of Korea, and by the World Health Organization Regional Office for the Western Pacific.In the National Lot Release Systems session countries including Canada, China, Japan, Malaysia, Vietnam, and the Republic of Korea, all shared information on their current Lot Release Systems, including current practices and developments in risk-based official lot release of vaccines.In the session on Quality Control of Blood Products, experts from the National Institute for Biological Standards and Control shared quality control and research results for; blood coagulation factor VIII products, and the measurement of procoagulant activity in immunoglobulin products. Representatives from Japan proposed a regional collaborative study to test aggregated immunoglobulin free from complement activity. A cell-based Japanese encephalitis vaccine potency assay was proposed by representatives from Korea and they also called for voluntary participation of other National Control Laboratories in a collaborative study, on the first Korean Gloydius anti-venom standard. Participants agreed in general to continue communicating, and coordinate presentation of the study results.
机译:大韩民国食品药品安全部国家食品药品安全评估研究所和世界卫生组织联合组织了西太平洋国家疫苗和生物制剂国家控制实验室第二次会议西太平洋区域办事处。在全国抽签制度会议上,包括加拿大,中国,日本,马来西亚,越南和大韩民国在内的所有国家都共享了有关其当前抽签制度的信息,包括有关风险的现行做法和发展在血液制品的质量控制会议上,美国国家生物标准与控制研究所的专家分享了质量控制和研究结果;凝血因子VIII产品,以及免疫球蛋白产品中促凝活性的测量。日本代表提出了一项区域合作研究,以测试没有补体活性的聚集免疫球蛋白。韩国代表提出了一种基于细胞的日本脑炎疫苗效价测定方法,他们还呼吁其他国家控制实验室自愿参与第一个韩国Gloydius抗毒标准的合作研究。参加者总体上同意继续沟通,并协调研究结果的介绍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号